Molecular Biology Testing in NSCLC

Format: Webcourse
Credit(s): 0.25 (15 min)
Release Date: Jun 17, 2020
Expiration Date: Jun 17, 2021
Credit Type(s):
  • CME / AMA PRA Category 1 Credit™
  • MOC / ABIM MOC Part 2 Credit
  • MIPS Improvement Activity Under MACRA


This adaptive-learning module will provide participants with a comprehensive review of the role of molecular testing in the decision-making process for patients with non-small cell lung cancer (NSCLC). Various methods of molecular testing will be discussed.


Molecular Testing Targets


This activity is intended for oncologists and other healthcare professionals involved in the treatment and care of patients with lung cancer.


At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Utilize molecular testing to help guide treatment decisions for patients with advanced NSCLC
  • Evaluate the updated clinical guidelines for first-line treatment of advanced NSCLC


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.


The Potomac Center for Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email


Leora Horn, MD, MSc, FRCPC
Ingram Associate Professor of Cancer Research
Director, Thoracic Oncology Research Program
Assistant Vice Chairman for Faculty Development
Vanderbilt Ingram Cancer Center
Nashville, TN
Mitra Mehrad, MD
Assistant Professor
Associate Director, Surgical Pathology Fellowship
Pathology, Microbiology and Immunology
Vanderbilt University Medical Center
Nashville, TN


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.


Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Molecular Biology Testing in NSCLC has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Internal Medicine

MOC Part II CME Activity
Family Medicine
Medical Genetics and Genomics


Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).


The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.

Faculty, Authors and Content Developers
The faculty, authors and content developers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Leora Horn, MD, MSc, FRCPC: Consultant/Independent Contractor: AstraZeneca, Amgen, Bayer, EMD Serono, Incyte, Merck, Pfizer, Xcovery; Grant/Research Support: Bristol-Myers Squibb, Boehringer Ingelheim, Xcovery

Mitra Mehrad, MD: Nothing to disclose

Josh Kilbridge: Nothing to disclose

Planners and Managers
The planners and manger reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Chelsey Goins, PhD; Joanne M. Fayal; Blair St. Amand: Nothing to disclose

Content Reviewers
The content reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Katie Propst, PhD; Lindsay Scott, PT, DPT, ATC: Nothing to disclose


The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 50% or better, and evaluation. The estimated time for completion of this activity is 15 minutes. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.


Jointly provided by the Potomac Center for Medical Education and Rockpointe

  Physician CME


This activity is not supported by any grantor or commercial interest.


X-Linked Hypophosphatemia: Improving Clinician Awareness and Management

Learn More

Vaping and Teens: Strategies to Help Stem the Tide

Learn More

Vaping and Teens: Strategies to Help Stem the Tide

Credits 1.00 (60 min)

Format Webcourse

Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint

Learn More
This entry was posted in . Bookmark the permalink.

Follow Us :

Follow Us :

© 2021 Rockpointe Corporation

Privacy Policy

© 2021 Rockpointe Corporation

Privacy Policy